Diseases [C] » Immune System Diseases [C20] » Hypersensitivity
Description
Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. MeSH
Hierarchy View
Subtype Terms (8)
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome
13 drugs (9 approved, 4 experimental)
Environmental Illness
1 experimental drug
Hypersensitivity, Delayed
4 drugs (2 approved, 2 experimental)
Hypersensitivity, Immediate
47 drugs (29 approved, 18 experimental)
Immune Complex Diseases
1 approved drug
Approved Indicated Drugs (36)
Phase 4 Indicated Drugs (27)
Phase 3 Indicated Drugs (21)
Phase 2 Indicated Drugs (21)
Phase 1 Indicated Drugs (16)
Other Experimental Indicated Drugs (40)
Organization Involved with Phase 4 Indications (91)
Beijing Bionovo Medicine Development Co., Ltd.
Catholic University of Sacred Heart, Rome
Chinese Academy of Medical Sciences
Chinese University of Hong Kong
Dezhou People's Hospital,Shandong
Dongying People's Hospital, Shandong
Fundação de Amparo à Pesquisa do Estado de São Paulo
Hospital General de México Dr. Eduardo Liceaga
Indian Council of Medical Research
Jiangsu Kanion Pharmaceutical Co., Ltd
Jining City Dermatology Hospital Prevention and Treatment
Katholieke Universiteit Leuven
Kidwai Memorial Institute of Oncology, Bangalore
Laiwu City Dermatology Hospital Prevention and Treatment
Linyi City Dermatology Hospital Prevention and Treatment
People's Liberation Army of China
Postgraduate Institute of Medical Education and Research
Riyadh Colleges of Dentistry and Pharmacy
Rizhao City Dermatology Hospital Prevention and Treatment
Shandong Jining No. 1 People's Hospital
Shandong Province Qianfoshan Hospital
Shandong Provincial Institute of Dermatology and Venereology
Silesian University of Medicine
Sitaram Bhartia Institute of Science and Research
Terezinha de Jesus Esteves Barata
The University of Texas, Dallas
Tianjin University of Traditional Chinese Medicine
Organization Involved with Phase 3 Indications (95)
Arbeitsgemeinschaft Gynaekologische Onkologie Austria
Australia New Zealand Gynaecological Oncology Group
Cooperative Ovarian Cancer Group for Immunotherapy Network
Dow University of Health Sciences
Facing Our Risk of Cancer Empowered
Global Alliance for TB Drug Development
Grupo Medifarma, S. A. de C. V.
Huazhong University of Science and Technology
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Aging (NIA)
Oklahoma Medical Research Foundation
Scottish Gynaecological Cancer Study Group
Organization Involved with Phase 2 Indications (149)
Advanced Accelerator Applications
American Society of Clinical Oncology
Assistance Publique - Hôpitaux de Paris
Cancer Research and Biostatistics Clinical Trials Consortium
Consortium of Food Allergy Research
Federal University of Amazonas
Federal University of Minas Gerais
Food Allergy Research and Education
Gordon Sussman Clinical Research
Government Dental College and Research Institute, Bangalore
Hoosier Cancer Research Network
Hospital Universitario Infanta Elena
Icahn School of Medicine at Mount Sinai
Istituto Oncologico Veneto IRCCS
Jiangsu Cancer Institute & Hospital
Mast Cell Pharmaceuticals Inc.
Medical Oncology 2, Istituto Oncologico Veneto
Memorial Sloan-Kettering Cancer Center
National Center for Complementary and Integrative Health (NCCIH)
National Institute of General Medical Sciences (NIGMS)
National University of Singapore
North Eastern Germany Society of Gynaecologic Oncology
Norwegian Diabetes Association
Oregon Health and Science University
Resistentia Pharmaceuticals AB
Southeastern Gynecologic Oncology
South-Eastern Norway Regional Health Authority
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
The European Uro-Oncology Group
Translational Research in Oncology
Universidad Autonoma de Madrid
Universidade Federal de Minas Gerais
Organization Involved with Other Experimental Indications (100)
American College of Allergy, Asthma and Immunology
Bambino Gesù Hospital and Research Institute
Federal University of Health Science of Porto Alegre
Federal University of Rio Grande do Sul
Federal University of Uberlandia
Hochgebirgsklinik Davos, Switzerland
Liverpool John Moores University
Medical Research Council, Sweden
Medical University of Bialystok
Nanjing University of Traditional Chinese Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Ostergotland County Council, Sweden
Southern California College of Optometry
Tamil Nadu Dr.M.G.R.Medical University
Technical University of Denmark
The Danish Council for Strategic Research
The Ekhaga Foundation, Stockholm, Sweden
The Swedish Asthma and Allergy Research Foundation, Stockholm
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.